Cellular Dynamics Following CAR T Cell Therapy Are Associated with Response and Toxicity in Relapsed/Refractory Myeloma

Scientists performed a comprehensive flow cytometry analysis of 27 relapsed/refractory multiple myeloma patients treated with Idecabtagene vicleucel to assess the expansion capacity, persistence and effects on bystander cells of B cell maturation antigen-targeting CAR T cells.